US 8575312
Compositions and methods of use for MGD-CSF in disease treatment
granted A61KA61K38/00A61P
Quick answer
US patent 8575312 (Compositions and methods of use for MGD-CSF in disease treatment) held by Five Prime Therapeutics, Inc. expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61P, A61P1/04, A61P1/14